Medpace Holdings, Inc. Quarterly Deferred Income Tax Expense (Benefit) in USD from Q1 2016 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Medpace Holdings, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2016 to Q1 2024.
  • Medpace Holdings, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$865K, a 18.6% increase year-over-year.
  • Medpace Holdings, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was -$25.1M, a 9.14% decline from 2022.
  • Medpace Holdings, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was -$23M, a 38% increase from 2021.
  • Medpace Holdings, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was -$37.1M, a 7142% decline from 2020.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$865K +$198K +18.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-23
Q1 2023 -$1.06M -$350K -49.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-23
Q1 2022 -$713K -$2M -155% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-25
Q1 2021 $1.29M +$210K +19.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-26
Q1 2020 $1.08M +$423K +64.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-27
Q1 2019 $656K +$904K Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-29
Q1 2018 -$248K +$162K +39.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-30
Q1 2017 -$410K -$100K -32.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-01
Q1 2016 -$310K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.